Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Trillium Therapeutics Inc. V.SSS

Sector: Healthcare | Sub-Sector: Biotechnology
Primary Symbol: T.TR
Alternate Symbol(s):  SCTPD| SCTPF

Price: N/A | Change: N/A | %Change: N/A
Volume: 0 | Day High/Low: N/A/N/A | 52 Week High/Low: N/A/N/A
View modes: 
0 stars

RE:RE:RE:All quiet here lately

Good points HnG. After taking some serious hits in the minerals and energy sectors over the last couple of years, I've made a significant move into health care and have a nice basket of more
0 stars

RE:RE:All quiet here lately

Hi retiredCF, I agree that it would be fantastic to hear some news stories about this on the Canadian side of the line and also some airplay on BNN and other business segments on the news.   But, more
0 stars

RE:All quiet here lately

schwat - In contrast to your "ton of analyst" comments, from where I sit, there actually seems to be very little coverage of TH, at least within the Canadian investment community, The analysts more
0 stars

All quiet here lately

We;ve had a lot to digest over the past few weeks. A ton of analyst have started coverage on Trillium. Their recommendations go from a "Strong Buy" to a "Sell". Pretty much (from what I more
3 stars

RE:RE:Taboo talk.

Howard, these people can think for themselves. Some will find my posts informative (on the cautionary side) and others will prefer to only read the upbeat "you'll never lose" posts. You're more
2.5 stars

RE:Taboo talk.

The only shot in the dark is you, RS. You have to rank up there with the most sickingly negative posters to ever lay their  c r a p  on us poor SH users - that you`ve made the comments that you` more
2.5 stars

Taboo talk.

Unfortunately it is totally relevant.   40% of Canadians will be diagnosed with cancer at some point in their life.  It can be extremely expensive. There are a few drugs on the market that are more
0 stars

wow, to the moon, maybe :-D

finaly, passed 30$ hope higher soon. for more $  rate and reply
0 stars


I Agree. I have been trying to find info from AGM to no success. Unfortunately I was out of the country and could not even call in! Any details anyone? Thanks! Schwat  rate and reply
0 stars


jw...would far prefer to hear your take (more than 140 characters is ok) on the agm. specifically....did tr give date for phase 1 to begin? how long will trial last? where will it take place? how more
0 stars


Was at AGM today. Rather than me posting what went on, Have a look at what a few of the people that were there have to say on Twitter......$TRIL  rate and reply
0 stars

RE:RE:RE:RE:RE:Good Friday

erudite....who knows where the sp will be....and...when the next "news" will be. we do know agm: 27 may. I expect nothing; guys who signed up for that 50 million dollar deal can start selling more
0 stars

RE:RE:RE:RE:Good Friday

So with the PT being $40 CDN, when does the current trading stop?  What will be the SP before the next big news release comes out?   Thoughts?   Of course, I'm hanging on till Pigs and Elephants more
0 stars

here we go again.....

here's somebody else who likes it...I guess..... Trillium Therapeutics - A Compelling Investment At Current Levels May. 18, 2015 4:37 PM ET | About: Trillium Therapeutics Inc. (TRIL), Includes: more
0 stars


this mofo up 13% today in NY.  looking good piggy!  rate and reply
0 stars

RE:RE:RE:RE:Good Friday

fly piggy fly!  be free piggy!  rate and reply
1 star

RE:RE:RE:Good Friday

I was correct so in Canadian dollars, the target is close to $40.00. GLTA Trillium Therapeutics Inc. (TRIL-Q; TR-T) was rated new “outperform” at Oppenheimer. The 18-month target price is $32 ( more
0 stars

RE:RE:Good Friday

i like the target.  fly piggy fly!!!!  rate and reply
1 star

RE:Good Friday

Given that it's Oppenheimer, I'm assuming that their target is US$32.00. GLTA  rate and reply
0 stars

Good Friday

Great way to start the long weekend!! BUZZ-Trillium Therapeutics Inc: Oppenheimer starts with "outperform" rating 32 minutes ago - Reuters BUZZ-Trillium Therapeutics Inc: Oppenheimer starts more